In this article, we are going to take a look at where Resmed Inc (NYSE:RMD) stands against other stocks that Jim Cramer recently discussed. In his appearance on CNBC’s Squawk on the Street on Friday, ...

Shares of ResMed Inc. RMD rallied 1.07% to $247.66 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 3.26% to 5,844.19 and the ...

S hares of Resmed Inc. (RMD) traded over 7% higher in pre-market on Thursday morning after the company’s third-quarter earnings beat Wall Street estimates and the firm dismissed the impact from ...

Brett Fishbin; Analyst; KeyBanc Capital Markets Inc. Greetings, and welcome to the Q3 fiscal year 2025 ResMed earnings conference call. My name is Kevin, and I'll be your operator for today's call.

Free Cash Flow: Strong generation reported. ResMed Inc (NYSE:RMD) reported strong financial performance with an 8% increase in group revenue, reaching $1.29 billion for Q3 fiscal year 2025.

Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2025. Revenue increased by 8% to $1.3 billion; up 9% on a constant currency basis Gross margin improved ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

(RTTNews) - Resmed Inc (RMD) revealed a profit for its third quarter that increased from the same period last year The company's bottom line totaled $365.0 million, or $2.48 per share. This ...

Shares of ResMed Inc. RMD rose 1.46% to $239.95 Friday, on what proved to be an all-around positive trading session for the ...

Greetings, and welcome to the Q3 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. At this time, all participants are in a listen-only ...

and double-digit EPS growth resulting from solid customer demand for our best-in-class products and software solutions,” said Resmed’s Chairman and CEO, Mick Farrell. “We delivered 9% ...